期刊文献+

HPLC法测定乙胺吡嗪利福异烟片中有关物质的含量 被引量:2

Determination of related substances in ethambutol hydrochloride, pyrazinamide, rifampicin and isoniazid tablets by HPLC
原文传递
导出
摘要 目的建立HPLC法测定乙胺吡嗪利福异烟片中已知杂质醌式利福平、N-氧化利福平、3-甲酰利福霉素SV、利福霉素S、利福霉素B、利福霉素SV、吡嗪-2-羧酸、异烟酸和其他未知杂质的含量。方法采用Waters Atlantis T3色谱柱(250 mm×4.60 mm,5μm);流动相A为10 mmol·L^(-1)磷酸氢二钠溶液(用磷酸调节pH至6.8),流动相B为乙腈,梯度洗脱;流速1.0 mL·min^(-1);检测波长254 nm;柱温25℃;进样量20μL。已知杂质采用外标法、未知杂质采用不加校正因子的主成分自身对照法计算含量。结果各待测化合物分离度均良好,供试品中检出杂质含量均低于规定限度。结论所建立的HPLC法能够用于乙胺吡嗪利福异烟片中有关物质的含量测定。 Objective To establish an HPLC method for the determination of rifampicin quinone, rifampicin N-oxide, 3-formylrifamycin SV, rifamycin S, rifamycin B, rifamycin SV, 2-pyrazinecarboxylic acid, isonicotinic acid and other unknown impurities in ethambutol hydrochloride, pyrazinamide, rifampicin and isoniazid tablets. Methods The HPLC method was performed on a Waters Atlantis T3 column (250 mmx 4. 60 mm,5 p^m). Gradient elution was used, and the mobile phase A consisted of 10 mmol ~ L-1 dibasic sodium phosphate buffer ( adjusted to pH of 6. 8 with phosphoric acid) and the mobile phase B was acetonitrile. The flow rate was 1.0 mL 1 min-1. The detection wavelength was set at 254 nm. The column temperature was 25℃. Both the known and unknown impurities were determined by external standard method. Results Impurities could be separated well from rifampin, isoniazid and pyrazinamide and other impurities in tablets. The contents of all impurities were lower than the prescribed limits. Conclusion The established HPLC method is rapid and accurate for the determination of related substances in ethambutol hydrochloride, pyrazinamide, rifampicin and isoniazid tablets.
作者 丁冰 杨文玲 许华容 尹艺迪 毕开顺 李清 DING Bing;YANG Wenling;XU Huarong;YIN Yidi;BI Kaishun;LI Qing(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2018年第9期750-755,共6页 Journal of Shenyang Pharmaceutical University
基金 新药质量评价共性关键技术(2015010201)
关键词 乙胺吡嗪利福异烟片 有关物质 高效液相色谱法 ethambutol hydrochloride pyrazinamide rifampicin and isoniazid tablet related substance highperformance liquid chromatography
  • 相关文献

参考文献6

二级参考文献22

  • 1邹祺,郑永勇,李斌栋,吕春绪.吡嗪酰胺的合成研究[J].江苏化工,2005(z1):124-126. 被引量:4
  • 2蔡泽宇,周本宏,李嘉宇,郝玉萍,刘洁.离子对反相高效液相色谱法测定异福酰胺片中异烟肼及吡嗪酰胺含量[J].中国药师,2005,8(7):562-563. 被引量:2
  • 3USP31 - NF26. Vol 2:2459.
  • 4BP. 2009. Vol 1:1107.
  • 5WHO.固定剂量复方制剂注册指导原则[Z].2005.
  • 6EMEA.固定复方制剂的临床开发指导原则[Z].2009.
  • 7CDE.化学药物复方制剂的杂质研究思路[Z].2007.
  • 8Bhutani H,Singh S,Jindal KC,et al.Mechanistic explanationto the catalysis by pyrazinamide and ethambutol of reactionbetween rifampicin and isoniazid in anti-TB FDCs[J].JPharm Biomed Anal,2005,39(5):892-899.
  • 9WHO.A guide for national tuberculosis program[J/OL].http//www.who.int,2006-10-12.
  • 10WHO.Treatment of tuberculosis.guidelines for national program[J/OL].http//www.who.int,2006 -07-19.

共引文献15

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部